Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPROVE: IPTp-DP +/- Azithromycin in Pregnancy
NCT03208179Phase 3Completed
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Mar 2018
- Primary completion
- Mar 2020
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 3
01
Overview
Phase 3, randomised, single-blind trial of dihydroartemisinin + piperaquine and azithromycin in malaria, sexually transmitted infections (STI) and reproductive tract infections (RTI) (3 arms), sponsored by Liverpool School of Tropical Medicine. Primary endpoint: Adverse pregnancy outcome at 8 months. Started Mar 2018; status: completed.
02
Drugs
dihydroartemisinin + piperaquineazithromycin
03
Conditions
malariasexually transmitted infections (STI)reproductive tract infections (RTI)
Beyond the preview
Go deeper on NCT03208179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03208179.